blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2892518

EP2892518 - COMPOSITIONS FOR TREATING PARKINSON'S DISEASE [Right-click to bookmark this link]
Former [2015/29]NEW THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE
[2018/09]
StatusNo opposition filed within time limit
Status updated on  17.05.2019
Database last updated on 18.10.2024
FormerThe patent has been granted
Status updated on  08.06.2018
FormerGrant of patent is intended
Status updated on  08.03.2018
FormerExamination is in progress
Status updated on  03.11.2017
Most recent event   Tooltip03.07.2020Lapse of the patent in a contracting state
New state(s): CY, MK		published on 05.08.2020  [2020/32]
Applicant(s)For all designated states
Pharnext
11, rue des Peupliers
92130 Issy-les-Moulineaux / FR
[2018/28]
Former [2015/29]For all designated states
Pharnext
11 Rue des Peupliers
92130 Issy-les-Moulineaux / FR
Inventor(s)01 / COHEN, Daniel
7 Bis Rue Lelégard
92210 Saint Cloud / FR
02 / NABIROCHKIN, Serguei
49 avenue de Sully Prud'homme
F-92290 Chatenay Malabry / FR
03 / CHUMAKOV, Ilya
691 rue de la Noue
F-77000 Vaux Le Penil / FR
 [2018/28]
Former [2015/29]01 / COHEN, Daniel
132 rue Tennerolles
92210 Saint Cloud / FR
02 / NABIROCHKIN, Serguei
49 avenue de Sully Prud'homme
F-92290 Chatenay Malabry / FR
03 / CHUMAKOV, Ilya
691 rue de la Noue
F-77000 Vaux Le Penil / FR
Representative(s)Becker, Philippe, et al
Cabinet Becker & Associés
25 Rue Louis Le Grand
75002 Paris / FR
[N/P]
Former [2018/28]Becker, Philippe, et al
Cabinet Becker & Associés
25 rue Louis Le Grand
75002 Paris / FR
Former [2015/29]Becker, Philippe, et al
Cabinet Becker & Associés
25, rue Louis Le Grand
75002 Paris / FR
Application number, filing date13759492.504.09.2013
[2018/28]
WO2013EP68312
Priority number, dateEP2012030606305.09.2012         Original published format: EP 12306063
US201261696992P05.09.2012         Original published format: US 201261696992 P
[2015/29]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2014037416
Date:13.03.2014
Language:EN
[2014/11]
Type: A2 Application without search report 
No.:EP2892518
Date:15.07.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 13.03.2014 takes the place of the publication of the European patent application.
[2015/29]
Type: B1 Patent specification 
No.:EP2892518
Date:11.07.2018
Language:EN
[2018/28]
Search report(s)International search report - published on:EP01.05.2014
ClassificationIPC:A61K31/185, A61K31/195, A61K31/421, A61K31/197, A61K31/137, A61K31/403, A61K31/4164, A61K31/19, A61K31/4402, A61K31/445, A61K31/155, A61K31/138, A61K31/506, A61K31/4422, A61K31/64, A61K31/519, A61K31/222, A61K45/06, A61P25/16
[2018/09]
CPC:
A61K31/185 (EP,CN,EA,US); A61K31/13 (EP,CN,EA,US); A61K31/519 (CN,EA,US);
A61K31/135 (EP,CN,EA,US); A61K31/137 (CN,EA,US); A61K31/138 (CN,EA,US);
A61K31/155 (CN,EA,US); A61K31/165 (EP,CN,EA,US); A61K31/192 (CN,EA,US);
A61K31/195 (EP,CN,EA,US); A61K31/197 (CN,EA,US); A61K31/198 (CN,EA,US);
A61K31/216 (EA,US); A61K31/24 (EP,CN,EA,US); A61K31/27 (EP,CN,EA,US);
A61K31/343 (EP,CN,EA,US); A61K31/353 (EP,CN,EA,US); A61K31/403 (CN,EA,US);
A61K31/4045 (EP,CN,EA,US); A61K31/416 (EP,CN,EA,US); A61K31/4164 (CN,EA,US);
A61K31/4178 (EP,CN,EA,US); A61K31/4184 (EP,CN,EA,US); A61K31/42 (CN,EA,US);
A61K31/421 (CN,EA,US); A61K31/428 (EP,CN,EA,US); A61K31/44 (EP,EA,US);
A61K31/4402 (CN,EA,US); A61K31/4422 (CN,EA,US); A61K31/445 (CN,EA,US);
A61K31/4458 (EP,CN,EA,US); A61K31/4525 (EP,CN,EA,US); A61K31/48 (EP,CN,EA,US);
A61K31/485 (EP,CN,EA,US); A61K31/505 (EP,CN,EA,US); A61K31/506 (CN,EA,US);
A61K31/55 (EP,CN,EA,US); A61K31/551 (EP,CN,EA,US); A61K31/5513 (EP,CN,EA,US);
A61K31/64 (EP,CN,EA,US); A61K45/06 (CN,EA,US); A61P25/00 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/28 (EP);
A61P43/00 (EP) (-)
C-Set:
A61K31/135, A61K2300/00 (CN,EP);
A61K31/137, A61K2300/00 (EP,CN);
A61K31/138, A61K2300/00 (EP,CN);
A61K31/13, A61K2300/00 (EP,CN);
A61K31/155, A61K2300/00 (EP,CN);
A61K31/165, A61K2300/00 (CN,EP);
A61K31/185, A61K2300/00 (EP,CN);
A61K31/192, A61K2300/00 (CN,EP);
A61K31/195, A61K2300/00 (EP,CN);
A61K31/197, A61K2300/00 (CN,EP);
A61K31/198, A61K2300/00 (EP,CN);
A61K31/24, A61K2300/00 (EP,CN);
A61K31/27, A61K2300/00 (CN,EP);
A61K31/343, A61K2300/00 (EP,CN);
A61K31/353, A61K2300/00 (CN,EP);
A61K31/403, A61K2300/00 (CN,EP);
A61K31/4045, A61K2300/00 (CN,EP);
A61K31/4164, A61K2300/00 (CN,EP);
A61K31/416, A61K2300/00 (CN,EP);
A61K31/4178, A61K2300/00 (EP);
A61K31/4184, A61K2300/00 (EP);
A61K31/421, A61K2300/00 (EP);
A61K31/428, A61K2300/00 (EP);
A61K31/42, A61K2300/00 (EP);
A61K31/4402, A61K2300/00 (EP);
A61K31/4422, A61K2300/00 (EP);
A61K31/4458, A61K2300/00 (EP);
A61K31/445, A61K2300/00 (EP);
A61K31/44, A61K2300/00 (EP,US,CN);
A61K31/4525, A61K2300/00 (EP);
A61K31/485, A61K2300/00 (EP);
A61K31/48, A61K2300/00 (EP);
A61K31/505, A61K2300/00 (EP);
A61K31/506, A61K2300/00 (EP);
A61K31/519, A61K2300/00 (EP);
A61K31/5513, A61K2300/00 (EP);
A61K31/551, A61K2300/00 (EP);
A61K31/55, A61K2300/00 (EP);
A61K31/64, A61K2300/00 (EP)
(-)
Former IPC [2015/29]A61K31/13, A61K31/135, A61K31/137, A61K31/138, A61K31/155, A61K31/165, A61K31/185, A61K31/192, A61K31/195, A61K31/197, A61K31/198, A61K31/24, A61K31/27, A61K31/343, A61K31/353, A61K31/403
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/29]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:NEUE THERAPEUTISCHE ANSÄTZE ZUR BEHANDLUNG VON MORBUS PARKINSON[2015/29]
English:COMPOSITIONS FOR TREATING PARKINSON'S DISEASE[2018/09]
French:NOUVELLES APPROCHES THÉRAPEUTIQUES POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON[2015/29]
Former [2015/29]NEW THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE
Entry into regional phase18.03.2015National basic fee paid 
18.03.2015Designation fee(s) paid 
18.03.2015Examination fee paid 
Examination procedure18.03.2015Examination requested  [2015/29]
08.10.2015Amendment by applicant (claims and/or description)
02.11.2017Despatch of a communication from the examining division (Time limit: M04)
11.01.2018Reply to a communication from the examining division
09.03.2018Communication of intention to grant the patent
29.05.2018Fee for grant paid
29.05.2018Fee for publishing/printing paid
29.05.2018Receipt of the translation of the claim(s)
Divisional application(s)EP18175031.6  / EP3388062
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.11.2017
Opposition(s)12.04.2019No opposition filed within time limit [2019/25]
Fees paidRenewal fee
18.09.2015Renewal fee patent year 03
09.09.2016Renewal fee patent year 04
21.09.2017Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU04.09.2013
AL11.07.2018
AT11.07.2018
CY11.07.2018
CZ11.07.2018
DK11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
MK11.07.2018
NL11.07.2018
PL11.07.2018
PT11.07.2018
RO11.07.2018
RS11.07.2018
SE11.07.2018
SI11.07.2018
SK11.07.2018
SM11.07.2018
TR11.07.2018
IE04.09.2018
LU04.09.2018
MT04.09.2018
BE30.09.2018
CH30.09.2018
LI30.09.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
[2020/31]
Former [2020/30]HU04.09.2013
AL11.07.2018
AT11.07.2018
CZ11.07.2018
DK11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
NL11.07.2018
PL11.07.2018
PT11.07.2018
RO11.07.2018
RS11.07.2018
SE11.07.2018
SI11.07.2018
SK11.07.2018
SM11.07.2018
TR11.07.2018
IE04.09.2018
LU04.09.2018
MT04.09.2018
BE30.09.2018
CH30.09.2018
LI30.09.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2020/28]AL11.07.2018
AT11.07.2018
CZ11.07.2018
DK11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
NL11.07.2018
PL11.07.2018
PT11.07.2018
RO11.07.2018
RS11.07.2018
SE11.07.2018
SI11.07.2018
SK11.07.2018
SM11.07.2018
TR11.07.2018
IE04.09.2018
LU04.09.2018
MT04.09.2018
BE30.09.2018
CH30.09.2018
LI30.09.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2020/16]AL11.07.2018
AT11.07.2018
CZ11.07.2018
DK11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
NL11.07.2018
PL11.07.2018
RO11.07.2018
RS11.07.2018
SE11.07.2018
SI11.07.2018
SK11.07.2018
SM11.07.2018
TR11.07.2018
IE04.09.2018
LU04.09.2018
MT04.09.2018
BE30.09.2018
CH30.09.2018
LI30.09.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2020/08]AL11.07.2018
AT11.07.2018
CZ11.07.2018
DK11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
NL11.07.2018
PL11.07.2018
RO11.07.2018
RS11.07.2018
SE11.07.2018
SI11.07.2018
SK11.07.2018
SM11.07.2018
IE04.09.2018
LU04.09.2018
MT04.09.2018
BE30.09.2018
CH30.09.2018
LI30.09.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/40]AL11.07.2018
AT11.07.2018
CZ11.07.2018
DK11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
NL11.07.2018
PL11.07.2018
RO11.07.2018
RS11.07.2018
SE11.07.2018
SI11.07.2018
SK11.07.2018
SM11.07.2018
IE04.09.2018
LU04.09.2018
BE30.09.2018
CH30.09.2018
LI30.09.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/38]AL11.07.2018
AT11.07.2018
CZ11.07.2018
DK11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
NL11.07.2018
PL11.07.2018
RO11.07.2018
RS11.07.2018
SE11.07.2018
SI11.07.2018
SK11.07.2018
SM11.07.2018
IE04.09.2018
LU04.09.2018
BE30.09.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/37]AL11.07.2018
AT11.07.2018
CZ11.07.2018
DK11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
NL11.07.2018
PL11.07.2018
RO11.07.2018
RS11.07.2018
SE11.07.2018
SI11.07.2018
SK11.07.2018
SM11.07.2018
IE04.09.2018
LU04.09.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/33]AL11.07.2018
AT11.07.2018
CZ11.07.2018
DK11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
NL11.07.2018
PL11.07.2018
RO11.07.2018
RS11.07.2018
SE11.07.2018
SK11.07.2018
SM11.07.2018
IE04.09.2018
LU04.09.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/30]AL11.07.2018
AT11.07.2018
CZ11.07.2018
DK11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
NL11.07.2018
PL11.07.2018
RO11.07.2018
RS11.07.2018
SE11.07.2018
SK11.07.2018
SM11.07.2018
LU04.09.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/26]AL11.07.2018
AT11.07.2018
CZ11.07.2018
DK11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
NL11.07.2018
PL11.07.2018
RO11.07.2018
RS11.07.2018
SE11.07.2018
SK11.07.2018
SM11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/24]AL11.07.2018
AT11.07.2018
CZ11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
NL11.07.2018
PL11.07.2018
RO11.07.2018
RS11.07.2018
SE11.07.2018
SK11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/22]AL11.07.2018
AT11.07.2018
CZ11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
NL11.07.2018
PL11.07.2018
RO11.07.2018
RS11.07.2018
SE11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/12]AL11.07.2018
AT11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
NL11.07.2018
PL11.07.2018
RS11.07.2018
SE11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/11]AT11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
NL11.07.2018
PL11.07.2018
RS11.07.2018
SE11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/10]AT11.07.2018
FI11.07.2018
LT11.07.2018
NL11.07.2018
PL11.07.2018
RS11.07.2018
SE11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/08]FI11.07.2018
LT11.07.2018
NL11.07.2018
NO11.10.2018
IS11.11.2018
Former [2019/07]LT11.07.2018
NL11.07.2018
Former [2019/04]NL11.07.2018
Cited inInternational search[Y]US5677344  (GREENFIELD SUSAN A [GB], et al) [Y] 1,2,8-11,13 * the whole document *;
 [Y]WO02056892  (BRIGHAM & WOMENS HOSPITAL [US]) [Y] 1-3,5,8-11,13 * page 1, lines 1-9 * * page 3, lines 3-9 * * page 24; claims 64,69-72 * * page 32; claims 143,146 *;
 [Y]WO2008089212  (BIOLOGENE HOLDING LLC [US], et al) [Y] 1,2,6,8-11,13 * page 1, line 28 - page 2, lines 1,31 * * page 14; claims 1-3 * * page 6, lines 26,31 *;
 [IY]US2009076019  (TYERS MIKE [CA], et al) [I] 1,2,6,8-11,13 * page 1, paragraph 12 * * page 2, paragraph 21 * * page 7, paragraph 73 * * page 15, paragraph 135 * * page 8, paragraph 83 * * page 84; claims 11,15-17 * * page 6, paragraph 63 - paragraph 65 * [Y] 3-5,7,12;
 [Y]EP2322163  (PHARNEXT [FR]) [Y] 1-11,13 * page 29; claim 3 * * page 30, line 28 * * page 4, paragraph 20 * * pages 31, 32; claim 6 * * pages 13, 14, paragraph 82 *;
 [Y]WO2012067621  (CUREMARK LLC [US], et al) [Y] 1,2,8-11,13 * page 63, paragraph 235 *;
 [Y]WO2012076555  (FOND SANTA LUCIA [IT], et al) [Y] 1,2,5,7-11,13 * page 11, lines 6,7,20, 22,23 * * pages 41,42; claims 1,3,4,9 *;
 [YP]WO2012117073  (PHARNEXT [FR], et al) [YP] 1-6,8-11,13* page 67 - page 72 *;
 [Y]  - SUZUKI YOKO ET AL, "Antioxidant properties of carvedilol: Inhibition of lipid peroxidation, protein oxidation and superoxide generation", NEUROLOGICAL RESEARCH, MANEY PUBLISHING, GB, (20031001), vol. 25, no. 7, ISSN 0161-6412, pages 749 - 753, XP008165757 [Y] 1,2,4,8-11,13 * page 749, column left, paragraph 1st * * page 752 - page 753 *

DOI:   http://dx.doi.org/10.1179/016164103101202110
 [Y]  - "Therapeutic Category and Biological Activity Index: ANTIPARKINSONIAN ED - MARYADELE J O'NEIL (; ET AL) (EDS)", THE MERCK INDEX. AN ENCYCLOPEDIA OF CHEMICALS, DRUGS, AND BIOLOGICALS, WHITEHOUSE STATION, NJ, USA, (20060101), ISBN 978-0-911910-00-1, page 15, XP002688415 [Y] 6-11,13 * pages ther-15 *
 [Y]  - KENNETH A FOLLETT ET AL, "Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease", NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, BOSTON, MA, US, vol. 362, no. 22, doi:10.1056/NEJMOA0907083, ISSN 1533-4406, (20100603), pages 2077 - 2091, (20110302), XP002688416 [Y] 12 * the whole document *

DOI:   http://dx.doi.org/10.1056/NEJMOA0907083
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.